FDA warns public vs unregistered drugs

MANILA, Philippines - The Food and Drug Administration (FDA) yesterday warned the public against the use of unregistered medicine sold in the market.

The FDA said there are at least 20 unregistered drugs proliferating in the market that could pose health risks to consumers.  

It said that the safety and efficacy of unregistered drugs could not be ensured because they have not undergone government’s evaluation.

“Product registration is a measure that the government undertakes to ensure the safety of health products,” the FDA said.

Among the unregistered drugs sold in the market are Bisacodyl (Delax) 5 mg tablet; Conjugated Estrogens USP (Conjugase-0.625) 0.625 mg tablet; Bicalutamide 50 mg tablet; Isosorbide dinitrate (Hartsorb Sublingual) 5 mg tablet; Flunarazine (Sobelin) 5 mg capsule; Loratadine (Clatidyne) 10 mg tablet; Diclofenac Sodium + Misoprostol (Arthrotec 50) 50 mg/ 200 mcg tablet; Cetirizine.2HCl (Cetrizin) 10 mg tablet; Clindamycin (Clindacap-300) 300 mg tablet, and Simvastatin (Zimmex 20) 20 mg tablet.